Malmö, Sweden (July 3, 2023) - Svar Life Science today announced the adoption of a new advanced technology to enable the use of the Olink® high-throughput proteomics platform together with Svar CRO and its Biomarker Discovery Services.
The integration of Olink’s Novel Proteomics Solutions Technology will initially leverage high-throughput multiplex biomarker analysis to provide Svars' clients with specific, precise, high-sensitivity protein analysis to accelerate successful drug development.